» Articles » PMID: 39757988

Comparative Genetic Analysis of Blood and Semen Samples in Sperm Donors from Hunan, China

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2025 Jan 6
PMID 39757988
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: At present, most genetic tests or carrier screening are performed with blood samples, and the known carrier rate of disease-causing variants is also derived from blood. For semen donors, what is really passed on to offspring is the pathogenic variant in their sperm. This study aimed to determine whether pathogenic variants identified in the sperm of young semen donors are also present in their blood, and whether matching results for blood are consistent with results for sperm.

Methods: We included 40 paired sperm and blood samples from 40 qualified semen donors at the Hunan Province Human Sperm Bank of China. All samples underwent exome sequencing (ES) analysis, and the pathogenicity was assessed according to the American College of Medical Genetics (ACMG) guidelines. Scoring for sperm donation matching, which was based on gene scoring and variant scoring, was also used to assess the consistency of sperm and blood genetic test results.

Results: A total of 108 pathogenic (P)/likely pathogenic (LP) variants in 82 genes were identified. The highest carrier had 7 variants, and there was also one donor did not carry any P/LP variant. On average, each donor carried 2.7 P/LP variants. Among all the P/LP variants, missense mutation was the dominant type and most of them were located in exonic regions. Chromosome 1 harboured the largest number of variants and no pathogenic copy number variants (CNV) was identified in semen donors. The P/LP variant of all the 40 semen donors was consistent by comparing sperm and blood. Except for one case that was slightly different, the rest simulated matching results for blood were all consistent with results for sperm.

Conclusions: It is reasonable to choose either blood or sperm for genetic screening in semen donors.

References
1.
Landaburu I, Gonzalvo M, Clavero A, Ramirez J, Yoldi A, Mozas J . Genetic testing of sperm donors for cystic fibrosis and spinal muscular atrophy: evaluation of clinical utility. Eur J Obstet Gynecol Reprod Biol. 2013; 170(1):183-7. DOI: 10.1016/j.ejogrb.2013.06.022. View

2.
Gravina L, Foncuberta M, Estrada R, Barreiro C, Chertkoff L . Carrier frequency of the 35delG and A1555G deafness mutations in the Argentinean population. Impact on the newborn hearing screening. Int J Pediatr Otorhinolaryngol. 2007; 71(4):639-43. DOI: 10.1016/j.ijporl.2006.12.015. View

3.
Yasutomi M, Kunishima S, Okazaki S, Tanizawa A, Tsuchida S, Ohshima Y . ACTN1 rod domain mutation associated with congenital macrothrombocytopenia. Ann Hematol. 2015; 95(1):141-144. DOI: 10.1007/s00277-015-2517-6. View

4.
Shin D, Gilbert F, Goldstein M, Schlegel P . Congenital absence of the vas deferens: incomplete penetrance of cystic fibrosis gene mutations. J Urol. 1997; 158(5):1794-8; discussion 1798-9. DOI: 10.1016/s0022-5347(01)64131-4. View

5.
Kelsell D, Dunlop J, Stevens H, Lench N, Liang J, Parry G . Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 1997; 387(6628):80-3. DOI: 10.1038/387080a0. View